Abstract

MARICOTO, Tiago et al. Aurora consensus: cardiovascular risk of type 2 diabetic patients. Rev Port Med Geral Fam [online]. 2020, vol.36, n.3, pp.289-299. ISSN 2182-5173.  https://doi.org/10.32385/rpmgf.v36i3.12744.

Objective: To develop a consensus document, guided to general and family medicine clinical practice that addresses the key aspects of the drug management on type 2 diabetes and its cardiovascular risk. Methods: An expert panel composed of six family doctors undertaken a non-systematic literature search and review, gathering the main international clinical guidelines and the most relevant meta-analysis, clinical trials and reviews, and regarding the management of type 2 diabetes and its main cardiovascular outcomes. The selected references were further and exhaustively analysed and then summarized on brief statements for clinical practice. Results: We identified 23 different bibliographic references, including guidelines, meta-analysis, and clinical trials, from which a set of statements were developed, namely 13 statements for diabetic treatment, five for hypertension treatment, five for dyslipidaemia therapy and 10 for anti-platelet therapy. Conclusion: The management of type 2 diabetes and its main cardiovascular outcomes must be personalized at an individual level, a challenge that requires a comprehensive understanding. New drug therapies are now available, and they must be used in an incisive way to ensure good clinical control of type 2 diabetes and its further cardiovascular outcomes, and thus, reducing the risk for additional comorbidities.

Keywords : Type 2 diabetes; General practice; Family medicine; Cardiovascular risk.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )